NBER opens with AI-driven innovation rising in China and globally
avicgoldfarb · x · 2026-09-26
Opening the 2026 NBER Economics of AI conference: AI's role in driving innovation appears to be increasing both in China and globally; innovation is generally beneficial and potentially non-rivalrous. A featured study, "Does AI Accelerate Drug Development" by Pan Lejia et al., examines AI's effect on drug development timelines.
More from AGI Musings
- AI-drafted 166-page Navier-Stokes proof is correct but nearly unreadable for humans — Pascallisch · 2026-09-26
- One Year On: Blaise Aguera y Arcas' 'What Is Intelligence?' Still Resonates — soumitrashukla9 · 2026-09-26
- Researcher: your AI take doesn't have to fit a naive optimistic-vs-pessimistic axis — nabla_theta · 2026-09-26
- Debate: LLMs are made of human writing but experience time, identity and death differently — qualadder · 2026-09-26
- Leo Gao on AI views: boosting productivity and doomerism aren't mutually exclusive — nabla_theta · 2026-09-26
- Two years in, this practitioner says truly unattended AI content is a myth — Cold_Hall_5384 · 2026-09-26